Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by

Xin Chang1, Yi-Hang Song2, Tian Xia2

  • 1Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China; Department of Gastroenterology, the General Hospital of Central Theater Command, Wuhan, China.

Abstract

Insights

Macrophage-derived exosomes carrying miR-223 worsen inflammatory bowel disease (IBD) by disrupting the intestinal barrier. This study identifies miR-223 as a key player in IBD progression via TMIGD1 inhibition.

Area of Science:

  • Cell biology
  • Immunology
  • Gastroenterology

Background:

  • Exosomes mediate intercellular communication, transporting microRNAs (miRNAs) crucial for biological processes.
  • The role of macrophage-derived exosomes in inflammatory bowel disease (IBD) pathogenesis remains largely unexplored.

Purpose of the Study:

  • To investigate specific miRNAs within macrophage-derived exosomes in the context of IBD.
  • To elucidate the molecular mechanisms by which these exosomal miRNAs influence IBD development.

Main Methods:

  • Established a dextran sulfate sodium (DSS)-induced IBD mouse model.
  • Isolated exosomes from lipopolysaccharide (LPS)-stimulated murine bone marrow-derived macrophages (BMDMs) and performed miRNA sequencing.
  • Utilized lentiviruses to manipulate miRNA expression and employed Transwell co-cultures with mouse and human organoids to model IBD in vitro.

Main Results:

  • LPS-induced macrophages released exosomes that exacerbated IBD.
  • MiRNA sequencing identified miR-223 as a key exosomal miRNA.
  • Upregulated exosomal miR-223 worsened intestinal barrier dysfunction in vivo and in organoid models.
  • Identified TMIGD1 as a target gene inhibited by miR-223, contributing to barrier dysfunction.

Conclusions:

  • Macrophage-derived exosomal miR-223 plays a significant role in DSS-induced colitis progression.
  • Exosomal miR-223 induces intestinal barrier dysfunction by inhibiting the barrier-related factor TMIGD1.